Cervicle Cancer Vaccine
Were you looking for information about Gardasil? Cervicle cancer vaccine is a common misspelling and variation of Gardasil.
Gardasil® is a vaccine that can help prevent certain types of human papillomavirus (HPV) infections, including those responsible for many cases of cervical cancer. In addition to being a cervical cancer vaccine, it may also prevent vaginal and vulvar cancers, genital warts and other conditions caused by certain types of HPV. Recently, the vaccine was also approved to prevent anal cancer, as well as precancerous anal lesions, in males and females age 9 to 26.
The vaccine, which is given as a series of three injections, does not protect against all types of HPV; however, it does protect against four of the most common types. Gardasil has been approved for use in males and females from 9 to 26 years of age. There have been side effects reported with the vaccine; some of the more common include dizziness, upset stomach (nausea), and reactions at the injection site.
(For more information, see the full eMedTV article about Gardasil. This article contains more details concerning the cervical cancer vaccine, including information about clinical trials of the vaccine and the typical schedule for the three injections used to administer it.)